Press "esc" to clear
Go to Advanced Search
Showing results 5160 of 1233

Article ID: 701658

Reducing HIV, other STIs among young black women in South Africa

University of Illinois at Chicago

The University of Illinois at Chicago is one of eight universities awarded funding by the National Institutes of Health to prevent and treat sexually transmitted infections, including HIV, among adolescents and young adults in Africa and Brazil. Collectively, the international projects are known as Prevention and Treatment through a Comprehensive Care Continuum for HIV-affected Adolescents in Resource Constrained Settings (PATC3H).

4-Oct-2018 11:05 AM EDT

Article ID: 701571

University Venture Fund Ii Is First Money in Navigen Pharmaceuticals Seed Round

Sorenson Impact Center, David Eccles School of Business, University of Utah

he Sorenson Impact Center’s University Venture Fund - Impact Investing (UVF II) closed its first investment in a seed round into Salt Lake City-based Navigen, Inc.

3-Oct-2018 1:05 PM EDT

Article ID: 701334

New Details of HIV Life Cycle

University of Delaware

A new study, focusing on a small molecule called IP6 and the role it plays in the HIV life cycle, "opens a door for development of new treatments."

3-Oct-2018 9:00 AM EDT
  • Embargo expired:
    27-Sep-2018 11:00 AM EDT

Article ID: 701062

Researchers Find How Natural Killer Cells Regulate Protective HIV Antibodies

Duke Health

In the quest to develop a vaccine that triggers the immune system to prevent HIV infection, researchers have focused on identifying and eliciting a particular type of antibody that is capable of neutralizing the virus.

25-Sep-2018 10:05 AM EDT

Article ID: 700922

Affordable Care Act: Study Reveals Surprising Gaps in HIV Care Providers’ Knowledge

University of Virginia Health System

Providers in states that expanded Medicaid were more likely to believe that the law would improve HIV outcomes, the study found. However, providers in all states agreed that the law would improve healthcare outcomes in general for their HIV patients.

21-Sep-2018 12:05 PM EDT

Article ID: 700794

Researcher Receives $2.3 Million NIH Grant to Expand Youth-Friendly HIV Self-Testing

Saint Louis University

Nigerian youth are at the epicenter of an expanding HIV crisis in Sub-Saharan Africa. HIV testing is an important early entry point to accessing preventive education, care and treatment. Yet fewer than one in five Nigerian youth have been tested. A Saint Louis University study seeks to change this by developing and implementing Innovative Tools to Expand HIV Self-Testing (I-TEST) for at-risk youth ages 14-24.

19-Sep-2018 3:05 PM EDT

Article ID: 700501

NYU Meyers’ Joyce Anastasi Receives $3.5 Million NIH Grant to Study Non-Pharmacologic Treatment for Neuropathic Pain in People with HIV

New York University

Joyce Anastasi, PhD, DrNP, FAAN, Independence Foundation Professor at NYU Rory Meyers College of Nursing, was awarded a $3.5 million grant by the National Institutes of Health (NIH) to study whether stimulating acupuncture points can help manage HIV-related neuropathic pain.

13-Sep-2018 11:05 AM EDT

Article ID: 700457

With STDs at an all-time high, why aren’t more people getting a proven treatment? U-M team examines reasons

Michigan Medicine - University of Michigan

Nearly 2.3 million times last year, Americans learned they had a sexually transmitted disease. But despite these record-high infection rates for chlamydia and gonorrhea, most patients only receive treatment for their own infection – when they probably could get antibiotics or a prescription for their partner at the same time. A team of physicians examines the barriers that stand in the way of getting expedited partner therapy to more people.

12-Sep-2018 7:05 PM EDT

Article ID: 700119

UNC Cure Center and Cell Microsystems Receive NIH Contract for Single Cell HIV Diagnostic Assay

University of North Carolina Health Care System

The NIH has awarded the UNC HIV Cure Center and Cell Microsystems a Small Business Innovation and Research contract to develop an automated platform to quantify the latent HIV reservoir, a key step in finding a cure for the virus.

6-Sep-2018 12:05 PM EDT

Article ID: 699932

Synthetic DNA Technology Provides a Novel Strategy for Effective Delivery of a Complex Anti-HIV Agent

Wistar Institute

Wistar scientists have applied their synthetic DNA technology to engineer a novel eCD4-Ig anti-HIV agent and to enhance its potency in vivo, providing a new simple strategy for constructing complex therapeutics for infectious agents as well as for diverse implications in therapeutic delivery.

4-Sep-2018 1:05 PM EDT

Showing results 5160 of 1233

Chat now!